GDNF is a fast-acting potent inhibitor of alcohol consumption and relapse
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Previously, we demonstrated that the action of the natural alkaloid, ibogaine, to reduce alcohol (ethanol) consumption is mediated by the glial cell line-derived neurotrophic factor (GDNF) in the ventral tegmental area (VTA). Here we set out to test the actions of GDNF in the VTA on ethanol-drinking behaviors. We found that GDNF infusion very rapidly and dose-dependently reduced rat ethanol, but not sucrose, operant self-administration. A GDNF-mediated decrease in ethanol consumption was also observed in rats with a history of high voluntary ethanol intake. We found that the action of GDNF on ethanol consumption was specific to the VTA as infusion of the growth factor into the neighboring substantia nigra did not affect operant responses for ethanol. We further show that intra-VTA GDNF administration rapidly activated the MAPK signaling pathway in the VTA and that inhibition of the MAPK pathway in the VTA blocked the reduction of ethanol self-administration by GDNF. Importantly, we demonstrate that GDNF infused into the VTA alters rats' responses in a model of relapse. Specifically, GDNF application blocked reacquisition of ethanol self-administration after extinction. Together, these results suggest that GDNF, via activation of the MAPK pathway, is a fast-acting selective agent to reduce the motivation to consume and seek alcohol.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Context, ambiguity, and unlearning: sources of relapse after behavioral extinction
Bouton, M. E. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01546-9 · Cited by 1,662 · cited 2×
“Reacquisition, a rapid return of responding when the outcome is made available again after a period of extinction, is a measure of relapse (38, 39) that is especially relevant for therapies that seek to extinguish drugrelated behaviors (40).”
BackgroundSweatt, J. D. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00054.x · Cited by 1,131 · cited 3×
“Therefore, we first assessed whether intra-VTA infusion of a behaviorally effective dose of GDNF (10 g) activates ERK1/2, a key enzyme in the MAPK signaling pathway.”
BackgroundInfluentialKoob, G. F., Sanna, P. P., & Bloom, F. E. (1998) · Neuron · doi:10.1016/s0896-6273(00)80557-7 · Cited by 1,026
Wagner, F. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00367-0 · Cited by 739 · cited 2×
“Relapse to alcohol use is one of the core features of alcoholism and is the main problem in the treatment of alcohol dependence (36, 37).”
BackgroundMcBride, W. J., Murphy, J. M., & Ikemoto, S. (1999) · Behavioural Brain Research · doi:10.1016/s0166-4328(99)00022-4 · Cited by 574
Oral sucrose stimulation increases accumbens dopamine in the rat
Hajnal, A., Smith, G. P., & Norgren, R. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00282.2003 · Cited by 449
Anticraving Medications for Relapse Prevention: A Possible New Class of Psychoactive Medications
O’Brien, C. P. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.8.1423 · Cited by 405 · cited 2×
“Relapse to alcohol use is one of the core features of alcoholism and is the main problem in the treatment of alcohol dependence (36, 37).”
BackgroundA learning theory perspective on lapse, relapse, and the maintenance of behavior change.
Bouton, M. E. (2000) · Health Psychology · doi:10.1037/0278-6133.19.suppl1.57 · Cited by 341
Bachtell, R. K., Whisler, K., Karanian, D., & Self, D. W. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0133-1 · Cited by 154 · cited 1×
“Also, microinjection of a D2 agonist in the anterior part of the VTA decreases ethanol but not saccharin self-administration (52), and microinjection of D1/2 agonists/antagonists produces distinct effects on cocaine and sucrose self-administration (53).”
Background
Cited by
Intermittent ethanol access schedule in rats as a preclinical model of alcohol abuse
Carnicella, S., Ron, D., & Barak, S. (2014) · Alcohol · doi:10.1016/j.alcohol.2014.01.006 · Cited by 320
Self-citationAnimal models of drug relapse and craving
Venniro, M., Caprioli, D., & Shaham, Y. (2016) · Progress in Brain Research · doi:10.1016/bs.pbr.2015.08.004 · Cited by 319
Disruption of alcohol-related memories by mTORC1 inhibition prevents relapse
Barak, S., Liu, F., Hamida, S. B., Yowell, Q. V., Neasta, J., Kharazia, V., Janak, P. H., & Ron, D. (2013) · Nature Neuroscience · doi:10.1038/nn.3439 · Cited by 172
Self-citationMolecular mechanisms underlying alcohol-drinking behaviours
Ron, D., & Barak, S. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.85 · Cited by 165
Ray, L. A., Bujarski, S., Shoptaw, S., Roche, D. J., Heinzerling, K., & Miotto, K. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.10 · Cited by 118
Metadata
- Authors
- Carnicella, S., Kharazia, V., Jeanblanc, J., Janak, P. H., & Ron, D.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2008-06-10
- Volume
- 105
- Issue
- 23
- Pages
- 8114-8119
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2098104823
- Cited by
- 127
- References
- 9
- FWCI
- 4.01
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: GDNF is a fast-acting potent inhibitor of alcohol consumption and relapse. https://app.cochat.ai/papers/10.1073/pnas.0711755105
- The paper
- Carnicella, S., Kharazia, V., Jeanblanc, J., Janak, P. H., & Ron, D. (2008). GDNF is a fast-acting potent inhibitor of alcohol consumption and relapse. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0711755105
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.